National Household Survey on Drug Abuse, 2000

The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of...

Descripción completa

Guardado en:  
Detalles Bibliográficos
Autor Corporativo: United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies (Autor)
Tipo de documento: Electrónico Research Data
Lenguaje:Inglés
Publicado: [Erscheinungsort nicht ermittelbar] [Verlag nicht ermittelbar] 2002
En:Año: 2002
Acceso en línea: Volltext (kostenfrei)
Verificar disponibilidad: HBZ Gateway
Palabras clave:

MARC

LEADER 00000cam a22000002c 4500
001 184004814X
003 DE-627
005 20230325055101.0
007 cr uuu---uuuuu
008 230324s2002 xx |||||o 00| ||eng c
024 7 |a 10.3886/ICPSR03262.v5  |2 doi 
035 |a (DE-627)184004814X 
035 |a (DE-599)KXP184004814X 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 2,1  |2 ssgn 
110 2 |a United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies  |e VerfasserIn  |4 aut 
245 1 0 |a National Household Survey on Drug Abuse, 2000 
264 1 |a [Erscheinungsort nicht ermittelbar]  |b [Verlag nicht ermittelbar]  |c 2002 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2000 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained in the 2000 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. 
540 |a ICPSR Terms of Use 
650 4 |a Addiction 
650 4 |a Alcohol 
650 4 |a Alcohol abuse 
650 4 |a Alcohol consumption 
650 4 |a amphetamines 
650 4 |a barbiturates 
650 4 |a Cocaine 
650 4 |a controlled drugs 
650 4 |a drinking behavior 
650 4 |a Drug Abuse 
650 4 |a Drug dependence 
650 4 |a Drug treatment 
650 4 |a Drug use 
650 4 |a Drugs 
650 4 |a Hallucinogens 
650 4 |a Heroin 
650 4 |a Households 
650 4 |a inhalants 
650 4 |a Marijuana 
650 4 |a Mental Health 
650 4 |a Mental Health Services 
650 4 |a Methamphetamine 
650 4 |a Prescription Drugs 
650 4 |a sedatives 
650 4 |a Smoking 
650 4 |a stimulants 
650 4 |a Substance Abuse 
650 4 |a Substance Abuse Treatment 
650 4 |a tranquilizers 
655 7 |a Forschungsdaten  |0 (DE-588)1098579690  |0 (DE-627)857755366  |0 (DE-576)469182156  |2 gnd-content 
856 4 0 |u https://doi.org/10.3886/ICPSR03262.v5  |x Resolving-System  |z kostenfrei  |3 Volltext 
935 |a mkri 
951 |a BO 
ELC |a 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4296795511 
LOK |0 003 DE-627 
LOK |0 004 184004814X 
LOK |0 005 20230324125205 
LOK |0 008 230324||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-2619)ICPSR3262 
LOK |0 040   |a DE-2619  |c DE-627  |d DE-2619 
LOK |0 092   |o n 
LOK |0 852   |a DE-2619 
LOK |0 852 1  |9 00 
LOK |0 935   |a foda  |a nacj 
OAS |a 1 
ORI |a SA-MARC-krimdoka001.raw